Special verification opinion on the use of part of the over-raised funds of Sansure Biotech Inc. as permanent supplementary working capital by Western Securities Co., Ltd.
Announcement by Sansure Biotech Inc. regarding the use of some of the excess funds to permanently supplement working capital.
Review of Sansure Biotech Inc.'s use of partially idle raised funds for cash management by West Securities Co., Ltd.
Announcement from Sansure Biotech Inc. regarding the use of some temporarily idle raised funds for cash management.
Special report on the use of funds raised and actual usage for the first half of 2024 by Sansure Biotech Inc.
The semi-annual evaluation report of the 'Quality Improvement and Efficiency Enhancement, Returning Value' Action Plan for 2024 of Sansure Biotech Inc.
Announcement of the resolution of the fourth meeting of the second supervisory board of Sansure Biotech Inc. in 2024.
Announcement on the resolution of the fifth interim meeting of the second board of directors of Sansure Biotech Inc. in 2024.
Notice of the resolution of the third interim meeting of the second session of the Board of Supervisors of Sansure Biotech Inc. in 2024.
Articles of Association of Sansure Biotech Inc.
Announcement of Sansure Biotech Inc. about obtaining government subsidies.
Reply to the regulatory inquiry letter on information disclosure of Sansure Biotech Inc.'s 2023 annual report from Zhongshen Zhonghuan Accounting Firm (special general partnership)
Verification opinion on the reply to the regulatory inquiry letter on the disclosure of information in the 2023 annual report of sansure biotech inc. by western securities limited.
Announcement by Sansure Biotech Inc. regarding voluntary disclosure of the company's CE certification for related testing products in the European Union.
Legal opinion on the differentiated equity distribution of Sansure Biotech Inc. by Hunan Qiyuan Law Firm
Announcement of Shengxiang Biotechnology Co., Ltd. on participating in the 2023 Science and Technology Innovation Board Group Performance Briefing
Shengxiang Biotechnology Co., Ltd. 2023 Environmental, Social and Corporate Governance (ESG) Report
China Audit Zhonghuan Certified Public Accountants (Special General Partnership) Internal Control Audit Report on Shengxiang Biotechnology Co., Ltd.
Shengxiang Biotechnology Co., Ltd.'s 2023 Accounting Firm Performance Evaluation Report
Shengxiang Biotechnology Co., Ltd. 2023 Independent Director Debriefing Report (Cao Ya)
No Data